Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
Modulation of Gastric Sensitivity and Accommodation by Vagal Nerve Stimulation
Massachusetts General Hospital
65 participants
Nov 30, 2018
INTERVENTIONAL
Conditions
Summary
Explore the effects of auricular transcutaneous vagal nerve stimulation (taVNS) on brain and stomach outcomes in functional dyspepsia and gastroparesis patients.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Active or inactive taVNS delivered to the external ear at a moderate, non-painful level.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03603730